Purchase of AI Finder

The Food and Drug Administration's Virology and Immunochemistry unit has identified a need for the procurement of an AI sample finder compatible with Zeiss microscopes. This equipment is integral to the lot release testing process of the influenza virus vaccine, Flumist, supporting efficient and accurate sample analysis. The contract falls under NAICS code 334516, indicating it pertains to analytical laboratory instrument manufacturing, and is currently in a forecast stage without a finalized solicitation number or set-aside designation. The procurement process involves coordination through the FDA's acquisition team, with the CBER Acquisition Liaison serving as the primary point of contact. While specific location details for performance or office addresses have not been provided, the initiative underscores the agency's commitment to enhancing vaccine testing capabilities through advanced AI technology integration. The contracting officer and further contract details are yet to be determined, with industry participants encouraged to monitor official FDA channels for updates.